Stephens Reiterates “Overweight” Rating for Addus HomeCare (NASDAQ:ADUS)

Addus HomeCare (NASDAQ:ADUS)‘s stock had its “overweight” rating reaffirmed by equities research analysts at Stephens in a report released on Tuesday, Benzinga reports. They presently have a $115.00 target price on the stock. Stephens’ price objective suggests a potential upside of 7.39% from the stock’s current price.

A number of other analysts also recently issued reports on ADUS. Oppenheimer reissued an “outperform” rating and set a $118.00 price objective on shares of Addus HomeCare in a research report on Tuesday, March 26th. Barclays downgraded shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target for the company. in a research note on Tuesday, April 23rd. Bank of America increased their price target on Addus HomeCare from $115.00 to $118.00 and gave the company a “buy” rating in a research report on Tuesday. William Blair restated an “outperform” rating on shares of Addus HomeCare in a research note on Monday, February 5th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $102.00 price target on shares of Addus HomeCare in a research note on Thursday, February 29th. One investment analyst has rated the stock with a sell rating and eight have issued a buy rating to the company’s stock. According to MarketBeat, Addus HomeCare presently has an average rating of “Moderate Buy” and a consensus target price of $106.57.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $107.09 on Tuesday. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.18. The firm has a 50-day simple moving average of $99.03 and a 200-day simple moving average of $92.71. Addus HomeCare has a 52 week low of $78.35 and a 52 week high of $107.54. The stock has a market capitalization of $1.75 billion, a price-to-earnings ratio of 27.89, a price-to-earnings-growth ratio of 1.94 and a beta of 0.96.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.97 by $0.24. The firm had revenue of $280.70 million during the quarter, compared to analyst estimates of $279.49 million. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. Addus HomeCare’s quarterly revenue was up 11.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.84 earnings per share. On average, equities analysts predict that Addus HomeCare will post 4.38 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Addus HomeCare

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Principal Securities Inc. purchased a new stake in shares of Addus HomeCare in the 4th quarter valued at about $26,000. BluePath Capital Management LLC acquired a new stake in shares of Addus HomeCare in the third quarter valued at approximately $31,000. GAMMA Investing LLC acquired a new position in shares of Addus HomeCare in the 4th quarter valued at $34,000. Assetmark Inc. grew its position in Addus HomeCare by 17.1% during the 3rd quarter. Assetmark Inc. now owns 1,331 shares of the company’s stock worth $113,000 after purchasing an additional 194 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new position in Addus HomeCare in the 3rd quarter valued at about $189,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.